Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dana-Farber Cancer Institute
Research
Chemo drug boosts Daiichi Sankyo ADC in prostate cancer models
Daiichi Sankyo’s antibody-drug conjugate DS-7300a might be more effective against hard-to-treat prostate cancer when used with a chemotherapy drug.
Helen Floersh
Nov 16, 2023 7:35am
Precede's liquid biopsy uncovers transcriptional cancer markers
Oct 23, 2023 2:50pm
Dana-Farber's Precede debuts with $57M for blood biopsy tests
Oct 6, 2023 10:15am
Dana-Farber AI traces unknown cancers back to the source: study
Aug 7, 2023 11:35am
Roivant founder departs for White House bid—Chutes & Ladders
Feb 24, 2023 9:30am
Sanofi-backed biotech hauls in $70M series A for covalent bonds
Oct 14, 2022 6:30am